Cargando…

The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer

BACKGROUND: Prostate cancer is a risk factor for major depressive disorder. Recent psycho-oncology research suggests a potential role for male-specific mood-related symptoms in this relationship. Gender socialisation experiences may reinforce men’s anger and emotion suppression responses in times of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rice, Simon M, Kealy, David, Ogrodniczuk, John S, Seidler, Zac E, Denehy, Linda, Oliffe, John L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023872/
https://www.ncbi.nlm.nih.gov/pubmed/32104085
http://dx.doi.org/10.2147/CMAR.S237770
_version_ 1783498347206672384
author Rice, Simon M
Kealy, David
Ogrodniczuk, John S
Seidler, Zac E
Denehy, Linda
Oliffe, John L
author_facet Rice, Simon M
Kealy, David
Ogrodniczuk, John S
Seidler, Zac E
Denehy, Linda
Oliffe, John L
author_sort Rice, Simon M
collection PubMed
description BACKGROUND: Prostate cancer is a risk factor for major depressive disorder. Recent psycho-oncology research suggests a potential role for male-specific mood-related symptoms in this relationship. Gender socialisation experiences may reinforce men’s anger and emotion suppression responses in times of distress, and anger and emotion suppression may be implicated in pathways to, and maintenance of depression in prostate cancer. PATIENTS AND METHODS: Data were collected online from men with a self-reported diagnosis of prostate cancer (N=100; mean age 64.8 years). Respondents provided information regarding diagnosis and treatment, in addition to current experience of major depression and male-specific externalising symptoms. RESULTS: Prostate cancer diagnosis in the last 12 months occurred for 35.4% of the sample. Elevated major depression symptoms were observed for 49% of respondents, with 14% endorsing past 2-week suicide ideation. Parallel mediation analysis (99% CIs) controlling for prostatectomy and active surveillance indicated men’s emotion suppression mediated the relationship between anger and depression symptoms (R(2)=0.580). Trichotimised emotion suppression scores with control variables yielded a large multivariate effect (p<0.001, partial η(2)=0.199). Univariate moderate-sized effects were observed for emotion suppression comparisons for symptoms of depressed mood and sleep disturbance, and a large effect observed for guilt-proneness. CONCLUSION: Findings highlight the salience of anger in the experience of depression symptoms for men with prostate cancer. The mediating role of emotion suppression, which in turn was strongly linked to men’s feelings of guilt, suggests potential assessment and intervention targets. Future work should examine the role of androgen deprivation therapy and other treatments including active surveillance on the relationship between anger and depression in men with prostate cancer. Consideration of interventions focused on emotion processing skills in psycho-oncology settings may help reduce men’s reliance on emotion suppression as a strategy for coping with feelings of anger or guilt in the context of prostate cancer.
format Online
Article
Text
id pubmed-7023872
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70238722020-02-26 The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer Rice, Simon M Kealy, David Ogrodniczuk, John S Seidler, Zac E Denehy, Linda Oliffe, John L Cancer Manag Res Original Research BACKGROUND: Prostate cancer is a risk factor for major depressive disorder. Recent psycho-oncology research suggests a potential role for male-specific mood-related symptoms in this relationship. Gender socialisation experiences may reinforce men’s anger and emotion suppression responses in times of distress, and anger and emotion suppression may be implicated in pathways to, and maintenance of depression in prostate cancer. PATIENTS AND METHODS: Data were collected online from men with a self-reported diagnosis of prostate cancer (N=100; mean age 64.8 years). Respondents provided information regarding diagnosis and treatment, in addition to current experience of major depression and male-specific externalising symptoms. RESULTS: Prostate cancer diagnosis in the last 12 months occurred for 35.4% of the sample. Elevated major depression symptoms were observed for 49% of respondents, with 14% endorsing past 2-week suicide ideation. Parallel mediation analysis (99% CIs) controlling for prostatectomy and active surveillance indicated men’s emotion suppression mediated the relationship between anger and depression symptoms (R(2)=0.580). Trichotimised emotion suppression scores with control variables yielded a large multivariate effect (p<0.001, partial η(2)=0.199). Univariate moderate-sized effects were observed for emotion suppression comparisons for symptoms of depressed mood and sleep disturbance, and a large effect observed for guilt-proneness. CONCLUSION: Findings highlight the salience of anger in the experience of depression symptoms for men with prostate cancer. The mediating role of emotion suppression, which in turn was strongly linked to men’s feelings of guilt, suggests potential assessment and intervention targets. Future work should examine the role of androgen deprivation therapy and other treatments including active surveillance on the relationship between anger and depression in men with prostate cancer. Consideration of interventions focused on emotion processing skills in psycho-oncology settings may help reduce men’s reliance on emotion suppression as a strategy for coping with feelings of anger or guilt in the context of prostate cancer. Dove 2020-02-11 /pmc/articles/PMC7023872/ /pubmed/32104085 http://dx.doi.org/10.2147/CMAR.S237770 Text en © 2020 Rice et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Rice, Simon M
Kealy, David
Ogrodniczuk, John S
Seidler, Zac E
Denehy, Linda
Oliffe, John L
The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer
title The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer
title_full The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer
title_fullStr The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer
title_full_unstemmed The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer
title_short The Cost of Bottling It Up: Emotion Suppression as a Mediator in the Relationship Between Anger and Depression Among Men with Prostate Cancer
title_sort cost of bottling it up: emotion suppression as a mediator in the relationship between anger and depression among men with prostate cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023872/
https://www.ncbi.nlm.nih.gov/pubmed/32104085
http://dx.doi.org/10.2147/CMAR.S237770
work_keys_str_mv AT ricesimonm thecostofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT kealydavid thecostofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT ogrodniczukjohns thecostofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT seidlerzace thecostofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT denehylinda thecostofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT oliffejohnl thecostofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT ricesimonm costofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT kealydavid costofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT ogrodniczukjohns costofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT seidlerzace costofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT denehylinda costofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer
AT oliffejohnl costofbottlingitupemotionsuppressionasamediatorintherelationshipbetweenangeranddepressionamongmenwithprostatecancer